相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolution of early phase clinical trials in oncology
Nam Q. Bui et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Tissue-agnostic cancer drug pipeline grows, despite doubts
Ken Garber
NATURE REVIEWS DRUG DISCOVERY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Precision Targeted Therapy with BLU-667 for RET-Driven Cancers
Vivek Subbiah et al.
CANCER DISCOVERY (2018)
Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century
Fabien Calvo et al.
EUROPEAN JOURNAL OF CANCER (2018)
69OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
D S W Tan et al.
ANNALS OF ONCOLOGY (2018)
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial
Richard Adams et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Immuno-Oncology: The Third Paradigm in Early Drug Development
Juan Martin-Liberal et al.
TARGETED ONCOLOGY (2017)
Unveiling changes in the landscape of patient populations in cancer early drug development
Cinta Hierro et al.
ONCOTARGET (2017)
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Edward L. Korn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Christophe Massard et al.
CANCER DISCOVERY (2017)
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Edward L. Korn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Early Phase Clinical Trial Designs - State of Play and Adapting for the Future
J. A. Harrington et al.
CLINICAL ONCOLOGY (2017)
Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program
Sonya Das et al.
CONTEMPORARY CLINICAL TRIALS (2017)
Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
Peter Bauer et al.
STATISTICS IN MEDICINE (2016)
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Research methods to change clinical practice for patients with rare cancers
Lucinda Billingham et al.
LANCET ONCOLOGY (2016)
I-SPY 2-Toward More Rapid Progress in Breast Cancer Treatment
Lisa A. Carey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Uncertainty in the Era of Precision Medicine
David J. Hunter
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Basket Trials and the Evolution of Clinical Trial Design in an Era of Genomic Medicine
Amanda J. Redig et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
NCI-MATCH trial pushes cancer umbrella trial, paradigm
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2015)
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M. Hyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test
Rodrigo Dienstmann et al.
MOLECULAR ONCOLOGY (2015)
Adaptive Prediction Model in Prospective Molecular Signature-Based Clinical Studies
Guanghua Xiao et al.
CLINICAL CANCER RESEARCH (2014)
Cancer Core Europe: A consortium to address the cancer care - Cancer research continuum challenge
Alexander M. M. Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2014)
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Jessica Menis et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept
Alberto Ocana et al.
CLINICAL CANCER RESEARCH (2013)
Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
Rodrigo Dienstmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
Tea Pemovska et al.
CANCER DISCOVERY (2013)
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Swen Hoelder et al.
MOLECULAR ONCOLOGY (2012)
Molecular prescreening to select patient population in early clinical trials
Jordi Rodon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Intratumor Heterogeneity: Seeing the Wood for the Trees
Timothy A. Yap et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Adaptive designs in clinical drug development - An Executive Summary of the PhRMA Working Group
Paul Gallo et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2006)
分享论文
